Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

XENE

Xenon Pharmaceuticals Inc

Jun 08 • 11:03AM ET

51.68

-0.05 -0.11 %

Healthcare • Biotechnology • Canada • Mid • NASD

Peers: ACAD AXSM INCY NBIX BMRN VKTX MDGL ALKS KROS BIIB

| Held by: IWM IWO IBB VTWO SPDW FESM VTWG SBIO NUSC VT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-4.70	Insider Own	6.16%	Shs Outstand	96.62M	Perf Week	-3.25%
Market Cap	5.00B	Forward P/E	-	EPS next Y	-4.93	Insider Trans	-5.73%	Shs Float	90.72M	Perf Month	-7.72%
Enterprise Value	3.91B	PEG	-	EPS next Q	-1.15	Inst Own	98.71%	Short Float	4.23%	Perf Quarter	-17.66%
Income	-383.17M	P/S	-	EPS this Y	-9.61%	Inst Trans	19.10%	Short Ratio	2.56	Perf Half Y	15.84%
Sales	0.00M	P/B	3.73	EPS next Y	-3.23%	ROA	-35.98%	Short Interest	3.83M	Perf YTD	15.30%
Book/sh	13.85	P/C	4.56	EPS next 5Y	8.51%	ROE	-37.53%	52W High	63.95 -19.19%	Perf Year	63.32%
Cash/sh	11.33	P/FCF	-	EPS past 3/5Y	-28.36% -40.02%	ROIC	-28.51%	52W Low	30.00 72.25%	Perf 3Y	21.56%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-7.36% -25.26%	Gross Margin	-	Volatility	3.68% 3.06%	Perf 5Y	169.84%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-46.29%	Oper. Margin	-	ATR (14)	1.73	Perf 10Y	616.72%
Dividend Ex-Date	-	Quick Ratio	27.79	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	36.39	Recom	1.05
Dividend Gr. 3/5Y	- -	Current Ratio	27.79	EPS Q/Q	-41.69%	SMA20	-4.37%	Beta	0.65	Target Price	80.56
Payout	-	Debt/Eq	0.01	Sales Q/Q	-100.00%	SMA50	-7.39%	Rel Volume	1.01	Prev Close	51.73
Employees	370	LT Debt/Eq	0.00	Earnings	May 07 AMC	SMA200	12.57%	Avg Volume	1.50M	Price	51.68
IPO	Nov 05, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	0.81% -100.00%	Trades		Volume	417,398	Change	-0.11%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)